Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name BI 836880
Trade Name
Synonyms BI836880|BI-836880|Bi-specific Anti-VEGF/Ang2 Nanobody BI 836880
Drug Descriptions

BI 836880 is a nanobody that binds to both VEGF and ANGPT2, which inhibits downstream signaling, potentially resulting in reduced tumor cell proliferation and inhibition of angiogenesis (NCI Drug Dictionary).

DrugClasses VEGF Antibody 10
CAS Registry Number 2254603-60-4
NCIT ID C126644

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BI 836880 BI 836880 0 0
BI 836880 + Effi-DEM + Ezabenlimab BI 836880 Effi-DEM Ezabenlimab 0 1
BI 836880 + Ezabenlimab BI 836880 Ezabenlimab 0 1


Additional content available in CKB BOOST